Read recent healthcare news from the FDA (Food and Drug Administration). Stay current on trends with our daily newsletter. Also, research insights with our curated search portal.
FDA finalizes PHE transition plan for medical devices
Becker's Healthcare March 27, 2023
FDA details plan to end emergency use authorizations
Healthcare DIVE March 24, 2023
FDA releases transition plans for medical device enforcement, authorization after COVID-19 public health emergency
American Hospital Association March 24, 2023
Matthew’s health care tidbits: The drug model for DTx was wrong
Health Care Blog March 24, 2023
New Life In Drug Importation
Health Affairs March 24, 2023
FDA outlines plan for digital health technologies for clinical trials
Regulatory Focus March 24, 2023
Research guides FDA action on common medical device
Medical Xpress March 23, 2023
Public Health Messages And The First Amendment: Graphic Warning Labels Struck Down
Health Affairs March 22, 2023
FDA to end some COVID-19 policies, revise others for long-term guidance
Becker's Healthcare March 21, 2023
HHS: FDA COVID-19 emergency use authorizations remain in effect
American Hospital Association March 17, 2023
FDA updates guidance on use of EHRs, digital tools in clinical trials
Becker's Healthcare March 16, 2023
FDA Announces Impact of Ending COVID-19 Public Health Emergency
Lexology March 16, 2023
FDA's Califf calls on insurers to help providers participate in critical clinical drug trials
Fierce Healthcare March 16, 2023
A Challenging Regulatory Environment Means More Care Needed with FDA Submissions
Lexology March 15, 2023
FDA to withdraw certain drug-related guidances with end of PHE
McKnight's March 14, 2023
Challenges to the FDA’s Approval of Medication Abortion Pills Could Curtail Access Throughout the United States
Kaiser Family Foundation March 14, 2023
Four Things that Healthcare Providers Need to Know About FDA Counterfeiting Investigations
JD Supra March 14, 2023
Legal Challenges to the FDA Approval of Medication Abortion Pills
Kaiser Family Foundation March 13, 2023
Eroding Judicial Deference to the FDA — Consequences for Public Health
NEJM March 11, 2023
HHS Leverages Data for Impact and Action at the 2023 Health Datapalooza
HHS Press Office March 10, 2023